引用本文:许晶,刘效巍,左萍萍,杨楠.慢性应激抑郁模型大鼠海马5-HT1A受体的变化[J].大连医科大学学报,2002,24(2):.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载  
分享到: 微信 更多
慢性应激抑郁模型大鼠海马5-HT1A受体的变化
许晶1, 刘效巍1, 左萍萍2, 杨楠2
1.大连医科大学第一临床学院神经内科,辽宁,大连,116011;2.中国医学科学院中国协和医科大学基础研究所药理教研室,北京,100005
摘要:
探讨慢性不可预见性应激抑郁模型大鼠海马5-HT1A受体(5-HT1AR)的变化以及三环类抗抑郁剂(TCAs)阿米替林和5-羟色胺再摄取抑制剂(SSRI)氟西汀对其影响。方法:将24只SD雄性大鼠随机均分为4组,即对照组、抑郁组、阿米替林治疗组、氟西汀治疗组。应用[3H]8-OH-DPAT作为放射性配基,使用放射性配体受体结合法测定大鼠海马5-HT1AR的特异性结合。结果:与对照组相比,抑郁组大鼠海马 [3H]8-OH-DPAT 特异性结合下降28.10%(P<0.05)。阿米替林治疗21 d,抑郁大鼠海马的[3H]8-OH-DPAT 特异性结合明显提高至(26.63±5.50) fmol/mg protein,与抑郁组(18.78±5.62) fmol/mg protein比较有显著性差异(P<0.05),与对照组(26.12±5.52) fmol/mg protein比较无显著性差异(P>0.05);氟西汀治疗21 d,抑郁大鼠海马的[3H]8-OH-DPAT特异性结合无显著变化(P>0.05)。结论:①抑郁大鼠海马5-HT1AR特异性结合下降可能与抑郁症病因相关。②海马 5-HT1AR可能是阿米替林发挥抗抑郁作用的环节。③氟西汀可能不通过影响海马突触后膜的5-HT1AR发挥抗抑郁作
关键词:  抑郁症  抗抑郁剂  应激  5-HT1A受体
DOI:10.11724/jdmu.2002.02.02
分类号:R749.4
基金项目:辽宁省科技厅资助项目
Change of 5-HT1A receptor in stress-induced depression rat hippocampus
XU Jing1, LIU Xiao-wei1, ZUO Ping-ping2
1.Department of Neurology,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;2.Department of Pharmacology, Institute of Basic Science,CAMB&PUMC,Beijing 100005,China.)
Abstract:
To investigate the change of 5-HT1A receptor (5-HT1AR) from chronic unpredicted mild stress depression rat hippocampus and the effect of Amitriptyline and Fluoxetine on 5-HT1AR in former depression model. Methods: Male Sprague-Dawley rats were randomly allocated to four groups as follows: control, depression model, depression model treated by Amitriptyline and depression model treated by Fluoxetine. The radioligand binding that used [3H]8-OH-DPAT as a radioactive ligand determines the special binding of 5-HT1AR. Results : The special binding of 5-HT1AR in model group decreased 28.10%,compared with control group (P<0.05). After Amitriptyline treatment the special binding of 5-HT1AR in model group obviously recover to the normal (P<0.05). The decreased 5-HT1AR was not effected by Fluoxetine (P>0.05). Conclusion: 1. It suggested that decreased 5-HT1AR in hippocampus may be associated with the etiology of depressive disorder. 2. The increased 5-HT1AR in hippocampus might be related to Amitriptyline's therapeutic effect in depressive disorder. 3. 5-HT1AR in hippocampus mightn't play a major role in the Fluoxetine's therapeutic effect of antidepressant treatment.
Key words:  depression  antidepressants  stress  5-HT1AR